Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch

Abbott, which already has a top-selling continuous glucose monitor for diabetes management known as Libre that generates more than $4 billion in sales annually, is developing a new line of biowearables known as Lingo that tracks glucose levels, ketones and lactate.